EBV BZLF1 (190-197)

EBV BZLF1 (190-197)
Please request pricing for this article.
Request Pricing

Item number Size Datasheet Manual SDS Delivery time Quantity Price
TGM-TP2720-10mg 10 mg - - -

7 - 10 business days*

-
TGM-TP2720-50mg 50 mg - - -

7 - 10 business days*

-
 
Description: EBVBZLF1 (190-197) is an immunodominant CEF control peptide derived from the... more
Product information "EBV BZLF1 (190-197)"
Description: EBVBZLF1 (190-197) is an immunodominant CEF control peptide derived from the Epstein-Barr virus (EBV). It serves as a suitable epitope for CD8+ T cells, facilitating the release of IFNg. The CD8 positive cytotoxic T lymphocytes (CTL) response to EBVBZLF1 (190-197) is diverse, capable of cross-recognizing similar peptide sequences from both host self-proteins and bacterial proteins. This peptide is also utilized in research on autoimmune diseases. Smiles: [C@H](CC1=CC=CC=C1)(C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@@H](CC(C)C)C(O)=O)=O)CC(C)C)=O)CCC(N)=O)=O)CCCCN)=O)NC([C@@H](NC([C@@H](NC([C@H](CCCNC(=N)N)N)=O)C)=O)CCCCN)=O
Supplier: TargetMol
Supplier-Nr: TP2720

Properties

Conjugate: No
MW: 1003.24 D
Formula: C47H82N14O10

Database Information

Handling & Safety

Storage: +4°C
Shipping: +20°C (International: +4°C)
Caution
Our products are for laboratory research use only: Not for administration to humans!
Information about the product reference will follow. more
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "EBV BZLF1 (190-197)"
Write a review
or to review a product.
Viewed